TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo September 1, 2023 Jeffrey S. Hackman Chief Executive Officer Comera Life Sciences Holdings, Inc. 12 Gill Street, Suite 4650 Woburn, MA 01801 Re: Comera Life Sciences Holdings, Inc. Registration Statement on Form S-3 Filed August 29, 2023 File No. 333-274253 Dear Jeffrey S. Hackman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan M. Rourke Reed, Esq.